VolitionRX Ltd (VNRX) reports a 59% revenue increase, driven by the Nu.Q Vet Cancer Test, while reducing operating expenses and advancing key studies and licensing deals.
2 weeks Ago By GuruFocus.com
VolitionRX Ltd (VNRX) reports a 59% revenue increase, driven by the Nu.Q Vet Cancer Test, while reducing operating expenses and advancing key studies and licensing deals..
The wind blew fast at the Chehalis Activators at W.F. West H...
